07:00 , Apr 27, 2015 |  BC Week In Review  |  Financial News

Bacterin financial update

Bacterin International Holdings Inc. (OTCQX:BONE), Belgrade, Mont.   Business: Supply/Service   Date announced: 2015-04-17   Note: Bacterin entered into a two-year stock purchase agreement with Aspire Capital Fund for up to $10 million.  ...
07:00 , Jul 28, 2014 |  BC Week In Review  |  Financial News

Bacterin financial update

Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont.   Business: Supply/Service   Date announced: 2014-07-23   Note: Bacterin implemented a 1-for-10 reverse stock split. Following the split, the company has about 5.5 million shares outstanding.  ...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Company News

Bacterin sales and marketing update

Bacterin launched OsteoSTX for use in orthopedic procedures, including multi-level spine procedures and deformity cases. The product consists of demineralized cortical sticks processed from human demineralized cancellous donated bone. The company could not be reached...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Bacterin completes debt financing

Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont.   Business: Supply/Service   Date completed: 3/10/14   Type: Debt financing   Raised: $4 million   Investor: OrbiMed Advisors   Note: Bacterin raised an additional $4 million under...
07:00 , Jul 1, 2013 |  BC Week In Review  |  Financial News

Bacterin financial update

Bacterin said NYSE MKT accepted the company's plan to regain compliance with requirements for continued listing. The company has until Nov. 13, 2014, to regain compliance. Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont.   Business:...
07:00 , Jun 10, 2013 |  BC Week In Review  |  Financial News

Bacterin proposes private placement of common stock and warrants

Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont.   Business: Supply/Service   Date announced: 6/5/13   Type: Private placement of common stock and warrants   To be raised: $4.9 million   Shares: 8.5 million   Price:...
07:00 , May 27, 2013 |  BC Week In Review  |  Financial News

Bacterin financial update

Bacterin received notice from NYSE MKT that the company is not in compliance with the minimum requirements for continued listing. The company has until Nov. 13, 2014, to regain compliance. Bacterin International Holdings Inc. (NYSE-M:BONE),...
08:00 , Jan 28, 2013 |  BC Week In Review  |  Clinical News

OsteoSponge musculoskeletal data

A retrospective analysis of 80 joints in 47 patients who underwent foot and ankle fusions showed that Bacterin's OsteoSponge led to a fusion rate of 97.5% as determined by radiographic analysis. Additionally, patients receiving OsteoSponge...
07:00 , Sep 3, 2012 |  BC Week In Review  |  Financial News

Bacterin completes debt financing

Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont.   Business: Supply/Service   Date completed: 8/28/12   Type: Debt financing   Raised: $20 million   Investor: OrbiMed Advisors   Note: The seven-year secured loan bears interest at...
07:00 , Sep 3, 2012 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) gained $0.20 to $20.56 last week after submitting an MAA to EMA for ponatinib to treat resistant or intolerant chronic myelogenous leukemia (CML) and Philadelphia-chromosome positive (Ph+) acute lymphoblastic...